Lumeris and MIT Partner to Enhance AI-Driven Primary Care
Lumeris has announced a strategic partnership with the MIT Computational Biology Lab to advance its AI-driven platform, Tom, which delivers Primary Care as a Service. Announced in a press release, the collaboration aims to integrate advanced computational models to improve understanding and guidance of individual and population health interventions.
The MIT Computational Biology Lab, led by Professor Manolis Kellis, is renowned for its expertise in using AI and data science to explore health and disease mechanisms. This partnership will leverage the lab's analytical techniques alongside Tom's proactive services and Lumeris' clinical workflow knowledge to enhance personalized and scalable primary care.
Tom, Lumeris' AI-powered platform, is embedded in primary care workflows to autonomously execute actions such as patient check-ins, scheduling screenings, and monitoring medications. The integration of dynamic modeling techniques from MIT will enable Tom to better anticipate future health events and deliver timely interventions, addressing the primary care gap affecting millions of Americans.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Linearis Joins Two Canadian AI Health Data Projects
Brainomix and Pulmonary Fibrosis Foundation Partner on AI Lung Imaging Research
LUNGevity Awards $2 Million for Lung Nodule Risk Studies
Lumana Partners With Convergint on AI Video Security
POMDOCTOR Outlines Predictive Healthcare Strategy
Daily AI Brief: the AI news that matters, in your inbox.